GlassScriptPhysician profile
Diana Huang
NPI 1467686162
$2,833.22
in general payments reported to CMS, 2019-2025
19 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.76 · 2020: $18.07 · 2021: $245 · 2022: $426 · 2023: $673 · 2024: $409 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $1,100.92 | 2021-2025 | Slynd, Tyblume, Nuvessa |
| Mayne Pharma Commercial LLC | $358.60 | 2022-2025 | |
| Novo Nordisk INC | $227.23 | 2025 | Wegovy |
| Astellas Pharma US INC | $174.14 | 2024-2025 | Veozah |
| Abbvie INC. | $151.79 | 2022-2023 | |
| Aspira Women'S Health INC | $128.10 | 2021-2025 | Ova1 |
| Evofem Biosciences, INC. | $114.55 | 2021-2025 | Phexxi, Solosec, Phexx |
| Janssen Pharmaceuticals, INC | $100.17 | 2021 | |
| Organon LLC | $90.97 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $83.59 | 2020-2025 | |
| Hologic Sales and Service, LLC | $75.11 | 2019-2025 | Aptima |
| Millicent US INC | $70.04 | 2025 | Femlyv |
| Avion Pharmaceuticals | $41.26 | 2022-2023 | Balcoltra |
| Allergan, INC. | $26.91 | 2019 | |
| Revance Therapeutics, INC. | $23.53 | 2025 | Daxxify |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $17.36 | 2025 | |
| Coopersurgical, INC. | $16.48 | 2025 | Paragard T 380a |
| Meditrina | $16.32 | 2025 | |
| Pfizer INC. | $16.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.